相关实验视频
Updated: Jul 21, 2025

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
跨导管大动脉置换后新的永久起器植入的预后影响
Hua-Jie Zheng1, Chao-Jun Yan1, De-Qing Lin1
1Department of Cardiac Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
概括
穿透导管大动脉置换 (TAVR) 后的永久心脏起器植入 (PPI) 是常见的. 虽然不增加死亡率,但新的PPI与更高的心力衰竭再住院和较差的LVEF改善有关.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏电生理学 心脏电生理学
背景情况:
- 需要永久心脏起器植入 (PPI) 的导电障碍是跨导管大动脉置换 (TAVR) 后的常见并发症.
- 关于TAVR后新的PPI临床影响的现有数据是相互矛盾的,需要进一步调查.
研究的目的:
- 评估新的永久心脏起器植入物 (PPI) 对经过过导管大动脉置换 (TAVR) 患者的临床结果的影响.
主要方法:
- 对从210名连续接受TAVR治疗严重症状性大动脉狭窄症患者的前性收集数据的回顾性分析.
- 评估30天,1年和2年的临床,心声和节奏数据.
主要成果:
- 在TAVR后30天内,16.7%的患者需要新的PPI,最常见的是高度心房静脉阻塞.
- 在患有或没有新的PPI的患者之间,没有观察到所有原因或心血管死亡率的显著差异.
- 接受新型PPI治疗的患者表现出心力衰竭再住院的风险更高 (调整后HR为1.53) 以及随着时间的推移缺乏LVEF改善.
结论:
- 在TAVR后30天内新的PPI与死亡率的增加无关.
- 然而,新的PPI与心力衰竭再住院的风险更大,以及TAVR后左心室射出小部分恢复受损的风险更大.
相关概念视频
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25

